February 21, 2025
11,001
382
90
4.29%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:43Now PlayingHims & Hers stock has been a mega-outperformer for investors, growing more than 600% over the past year, largely on the back of its compounded semaglutide products that mimic the effect of Ozempic and similar weight loss drugs from Big Pharma companies like Novo Nordisk and Eli Lilly.
👉 Subscribe to InvestingPro
1. 🚨 Trade Tracker
2.✅ Join LPP (Daily Live Trading)
3. 📸 Instagram
4. Apparel For Entrepreneurs
5.📊 Earn 20 FREE Stocks (WEBULL)
For those who are interested in Trading & Investing, I encourage you to join Our Free Trading Group of over 300,000
#HIMS #palantir #AINEWS #stockmarketnews
Thank you for the support, the best way to reach out to me is through our private discord chat, please DM me.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.